Abby Faye Jarrard, PAAA - Medicare Anesthesiology Assistant in Austell, GA

Abby Faye Jarrard, PAAA is a medicare enrolled "Anesthesiologist Assistant" in Austell, Georgia. She graduated from nursing school in 2009 and has 15 years of diverse experience with area of expertise as Anesthesiology Assistant. She is a member of the group practice Emory Specialty Associates, Llc and her current practice location is 3950 Austell Rd, Austell, Georgia. You can reach out to her office (for appointments etc.) via phone at (770) 732-5000.

Abby Faye Jarrard is licensed to practice in * (Not Available) (license number ) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1629203526.

Contact Information

Abby Faye Jarrard, PAAA
3950 Austell Rd,
Austell, GA 30106-1121
(770) 732-5000
Not Available



Provider's Profile

Full NameAbby Faye Jarrard
GenderFemale
SpecialityAnesthesiology Assistant
Experience15 Years
Location3950 Austell Rd, Austell, Georgia
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Abby Faye Jarrard graduated from nursing school in 2009
  NPI Data:
  • NPI Number: 1629203526
  • Provider Enumeration Date: 05/20/2009
  • Last Update Date: 01/24/2012
  Medicare PECOS Information:
  • PECOS PAC ID: 1557490703
  • Enrollment ID: I20100526000365

Medical Identifiers

Medical identifiers for Abby Faye Jarrard such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1629203526NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
367H00000XAnesthesiologist Assistant (* (Not Available))Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Emory Specialty Associates, Llc3476559782430

News Archive

Combination of cobimetinib and vemurafenib can halt progression of metastatic melanoma for one year

Data from the pivotal coBRIM Phase III study, presented by Lead Investigator Dr James Larkin today at the American Society of Clinical Oncology (ASCO) annual meeting, demonstrate that Roche's investigational MEK inhibitor cobimetinib, used in combination with BRAF inhibitor vemurafenib, typically offers people with previously untreated advanced metastatic melanoma (BRAFV600 mutation-positive unresectable or metastatic) one full year (median 12.3 months) without their disease worsening.

Familiar songs act as strong memory cues

Memories associated with music are strong. So strong that even the mere mention of a song's title or a glimpse of the album cover can bring the recollections of a time or place flooding back.

Saint Louis University creates new cancer education, prevention and research center

Saint Louis University (SLU) is creating a new cancer education, prevention and research center to improve the survival of St. Louis minorities - particularly African-American residents of north St. Louis city and county.

Canadians with a history of drug dependence more likely to have mental illness, finds study

New research published online in the International Journal of Mental Health and Addiction found that Canadians with a history of drug dependence are much less likely to have flourishing mental health and are more likely to have mental illness.

Insurance status linked to morbidity and mortality in patients undergoing total hip replacements

Insurance status is one marker of socioeconomic standing, and research has shown that uninsured and underinsured patients have worse outcomes following medical care.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Abby Faye Jarrard allows following entities to bill medicare on her behalf.
Entity NameThe Emory Clinic Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1396798229
PECOS PAC ID: 8820901408
Enrollment ID: O20031110000503

News Archive

Combination of cobimetinib and vemurafenib can halt progression of metastatic melanoma for one year

Data from the pivotal coBRIM Phase III study, presented by Lead Investigator Dr James Larkin today at the American Society of Clinical Oncology (ASCO) annual meeting, demonstrate that Roche's investigational MEK inhibitor cobimetinib, used in combination with BRAF inhibitor vemurafenib, typically offers people with previously untreated advanced metastatic melanoma (BRAFV600 mutation-positive unresectable or metastatic) one full year (median 12.3 months) without their disease worsening.

Familiar songs act as strong memory cues

Memories associated with music are strong. So strong that even the mere mention of a song's title or a glimpse of the album cover can bring the recollections of a time or place flooding back.

Saint Louis University creates new cancer education, prevention and research center

Saint Louis University (SLU) is creating a new cancer education, prevention and research center to improve the survival of St. Louis minorities - particularly African-American residents of north St. Louis city and county.

Canadians with a history of drug dependence more likely to have mental illness, finds study

New research published online in the International Journal of Mental Health and Addiction found that Canadians with a history of drug dependence are much less likely to have flourishing mental health and are more likely to have mental illness.

Insurance status linked to morbidity and mortality in patients undergoing total hip replacements

Insurance status is one marker of socioeconomic standing, and research has shown that uninsured and underinsured patients have worse outcomes following medical care.

Read more Medical News

› Verified 9 days ago

Entity NameEmory Specialty Associates, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1407864168
PECOS PAC ID: 3476559782
Enrollment ID: O20061010000447

News Archive

Combination of cobimetinib and vemurafenib can halt progression of metastatic melanoma for one year

Data from the pivotal coBRIM Phase III study, presented by Lead Investigator Dr James Larkin today at the American Society of Clinical Oncology (ASCO) annual meeting, demonstrate that Roche's investigational MEK inhibitor cobimetinib, used in combination with BRAF inhibitor vemurafenib, typically offers people with previously untreated advanced metastatic melanoma (BRAFV600 mutation-positive unresectable or metastatic) one full year (median 12.3 months) without their disease worsening.

Familiar songs act as strong memory cues

Memories associated with music are strong. So strong that even the mere mention of a song's title or a glimpse of the album cover can bring the recollections of a time or place flooding back.

Saint Louis University creates new cancer education, prevention and research center

Saint Louis University (SLU) is creating a new cancer education, prevention and research center to improve the survival of St. Louis minorities - particularly African-American residents of north St. Louis city and county.

Canadians with a history of drug dependence more likely to have mental illness, finds study

New research published online in the International Journal of Mental Health and Addiction found that Canadians with a history of drug dependence are much less likely to have flourishing mental health and are more likely to have mental illness.

Insurance status linked to morbidity and mortality in patients undergoing total hip replacements

Insurance status is one marker of socioeconomic standing, and research has shown that uninsured and underinsured patients have worse outcomes following medical care.

Read more Medical News

› Verified 9 days ago

Entity NameMak Anesthesia Cobb Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1699045070
PECOS PAC ID: 7810154960
Enrollment ID: O20120201000868

News Archive

Combination of cobimetinib and vemurafenib can halt progression of metastatic melanoma for one year

Data from the pivotal coBRIM Phase III study, presented by Lead Investigator Dr James Larkin today at the American Society of Clinical Oncology (ASCO) annual meeting, demonstrate that Roche's investigational MEK inhibitor cobimetinib, used in combination with BRAF inhibitor vemurafenib, typically offers people with previously untreated advanced metastatic melanoma (BRAFV600 mutation-positive unresectable or metastatic) one full year (median 12.3 months) without their disease worsening.

Familiar songs act as strong memory cues

Memories associated with music are strong. So strong that even the mere mention of a song's title or a glimpse of the album cover can bring the recollections of a time or place flooding back.

Saint Louis University creates new cancer education, prevention and research center

Saint Louis University (SLU) is creating a new cancer education, prevention and research center to improve the survival of St. Louis minorities - particularly African-American residents of north St. Louis city and county.

Canadians with a history of drug dependence more likely to have mental illness, finds study

New research published online in the International Journal of Mental Health and Addiction found that Canadians with a history of drug dependence are much less likely to have flourishing mental health and are more likely to have mental illness.

Insurance status linked to morbidity and mortality in patients undergoing total hip replacements

Insurance status is one marker of socioeconomic standing, and research has shown that uninsured and underinsured patients have worse outcomes following medical care.

Read more Medical News

› Verified 9 days ago

Entity NameMak Anesthesia, Nw Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1609202720
PECOS PAC ID: 4880820315
Enrollment ID: O20131111001715

News Archive

Combination of cobimetinib and vemurafenib can halt progression of metastatic melanoma for one year

Data from the pivotal coBRIM Phase III study, presented by Lead Investigator Dr James Larkin today at the American Society of Clinical Oncology (ASCO) annual meeting, demonstrate that Roche's investigational MEK inhibitor cobimetinib, used in combination with BRAF inhibitor vemurafenib, typically offers people with previously untreated advanced metastatic melanoma (BRAFV600 mutation-positive unresectable or metastatic) one full year (median 12.3 months) without their disease worsening.

Familiar songs act as strong memory cues

Memories associated with music are strong. So strong that even the mere mention of a song's title or a glimpse of the album cover can bring the recollections of a time or place flooding back.

Saint Louis University creates new cancer education, prevention and research center

Saint Louis University (SLU) is creating a new cancer education, prevention and research center to improve the survival of St. Louis minorities - particularly African-American residents of north St. Louis city and county.

Canadians with a history of drug dependence more likely to have mental illness, finds study

New research published online in the International Journal of Mental Health and Addiction found that Canadians with a history of drug dependence are much less likely to have flourishing mental health and are more likely to have mental illness.

Insurance status linked to morbidity and mortality in patients undergoing total hip replacements

Insurance status is one marker of socioeconomic standing, and research has shown that uninsured and underinsured patients have worse outcomes following medical care.

Read more Medical News

› Verified 9 days ago

Entity NameMak Anesthesia Decatur Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1720409147
PECOS PAC ID: 8224261433
Enrollment ID: O20140423001687

News Archive

Combination of cobimetinib and vemurafenib can halt progression of metastatic melanoma for one year

Data from the pivotal coBRIM Phase III study, presented by Lead Investigator Dr James Larkin today at the American Society of Clinical Oncology (ASCO) annual meeting, demonstrate that Roche's investigational MEK inhibitor cobimetinib, used in combination with BRAF inhibitor vemurafenib, typically offers people with previously untreated advanced metastatic melanoma (BRAFV600 mutation-positive unresectable or metastatic) one full year (median 12.3 months) without their disease worsening.

Familiar songs act as strong memory cues

Memories associated with music are strong. So strong that even the mere mention of a song's title or a glimpse of the album cover can bring the recollections of a time or place flooding back.

Saint Louis University creates new cancer education, prevention and research center

Saint Louis University (SLU) is creating a new cancer education, prevention and research center to improve the survival of St. Louis minorities - particularly African-American residents of north St. Louis city and county.

Canadians with a history of drug dependence more likely to have mental illness, finds study

New research published online in the International Journal of Mental Health and Addiction found that Canadians with a history of drug dependence are much less likely to have flourishing mental health and are more likely to have mental illness.

Insurance status linked to morbidity and mortality in patients undergoing total hip replacements

Insurance status is one marker of socioeconomic standing, and research has shown that uninsured and underinsured patients have worse outcomes following medical care.

Read more Medical News

› Verified 9 days ago

Entity NameMak Anesthesia Tch, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1730549676
PECOS PAC ID: 5890092910
Enrollment ID: O20160404001912

News Archive

Combination of cobimetinib and vemurafenib can halt progression of metastatic melanoma for one year

Data from the pivotal coBRIM Phase III study, presented by Lead Investigator Dr James Larkin today at the American Society of Clinical Oncology (ASCO) annual meeting, demonstrate that Roche's investigational MEK inhibitor cobimetinib, used in combination with BRAF inhibitor vemurafenib, typically offers people with previously untreated advanced metastatic melanoma (BRAFV600 mutation-positive unresectable or metastatic) one full year (median 12.3 months) without their disease worsening.

Familiar songs act as strong memory cues

Memories associated with music are strong. So strong that even the mere mention of a song's title or a glimpse of the album cover can bring the recollections of a time or place flooding back.

Saint Louis University creates new cancer education, prevention and research center

Saint Louis University (SLU) is creating a new cancer education, prevention and research center to improve the survival of St. Louis minorities - particularly African-American residents of north St. Louis city and county.

Canadians with a history of drug dependence more likely to have mental illness, finds study

New research published online in the International Journal of Mental Health and Addiction found that Canadians with a history of drug dependence are much less likely to have flourishing mental health and are more likely to have mental illness.

Insurance status linked to morbidity and mortality in patients undergoing total hip replacements

Insurance status is one marker of socioeconomic standing, and research has shown that uninsured and underinsured patients have worse outcomes following medical care.

Read more Medical News

› Verified 9 days ago

Entity NameMak Anesthesia Holdings, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1912452939
PECOS PAC ID: 4284917204
Enrollment ID: O20170216001563

News Archive

Combination of cobimetinib and vemurafenib can halt progression of metastatic melanoma for one year

Data from the pivotal coBRIM Phase III study, presented by Lead Investigator Dr James Larkin today at the American Society of Clinical Oncology (ASCO) annual meeting, demonstrate that Roche's investigational MEK inhibitor cobimetinib, used in combination with BRAF inhibitor vemurafenib, typically offers people with previously untreated advanced metastatic melanoma (BRAFV600 mutation-positive unresectable or metastatic) one full year (median 12.3 months) without their disease worsening.

Familiar songs act as strong memory cues

Memories associated with music are strong. So strong that even the mere mention of a song's title or a glimpse of the album cover can bring the recollections of a time or place flooding back.

Saint Louis University creates new cancer education, prevention and research center

Saint Louis University (SLU) is creating a new cancer education, prevention and research center to improve the survival of St. Louis minorities - particularly African-American residents of north St. Louis city and county.

Canadians with a history of drug dependence more likely to have mental illness, finds study

New research published online in the International Journal of Mental Health and Addiction found that Canadians with a history of drug dependence are much less likely to have flourishing mental health and are more likely to have mental illness.

Insurance status linked to morbidity and mortality in patients undergoing total hip replacements

Insurance status is one marker of socioeconomic standing, and research has shown that uninsured and underinsured patients have worse outcomes following medical care.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Abby Faye Jarrard is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Abby Faye Jarrard, PAAA
5665 New Northside Dr Nw Ste 320,
Atlanta, GA 30328-5834

Ph: (770) 874-5400
Abby Faye Jarrard, PAAA
3950 Austell Rd,
Austell, GA 30106-1121

Ph: (770) 732-5000

News Archive

Combination of cobimetinib and vemurafenib can halt progression of metastatic melanoma for one year

Data from the pivotal coBRIM Phase III study, presented by Lead Investigator Dr James Larkin today at the American Society of Clinical Oncology (ASCO) annual meeting, demonstrate that Roche's investigational MEK inhibitor cobimetinib, used in combination with BRAF inhibitor vemurafenib, typically offers people with previously untreated advanced metastatic melanoma (BRAFV600 mutation-positive unresectable or metastatic) one full year (median 12.3 months) without their disease worsening.

Familiar songs act as strong memory cues

Memories associated with music are strong. So strong that even the mere mention of a song's title or a glimpse of the album cover can bring the recollections of a time or place flooding back.

Saint Louis University creates new cancer education, prevention and research center

Saint Louis University (SLU) is creating a new cancer education, prevention and research center to improve the survival of St. Louis minorities - particularly African-American residents of north St. Louis city and county.

Canadians with a history of drug dependence more likely to have mental illness, finds study

New research published online in the International Journal of Mental Health and Addiction found that Canadians with a history of drug dependence are much less likely to have flourishing mental health and are more likely to have mental illness.

Insurance status linked to morbidity and mortality in patients undergoing total hip replacements

Insurance status is one marker of socioeconomic standing, and research has shown that uninsured and underinsured patients have worse outcomes following medical care.

Read more News

› Verified 9 days ago


Anesthesiologist Assistant Nurses in Austell, GA

Maggi Stuart Markwell,
Anesthesiologist Assistant
Medicare: Medicare Enrolled
Practice Location: 3950 Austell Rd, Austell, GA 30106
Phone: 770-732-4000    
Bhavik Dhyanesh Mehta, AA
Anesthesiologist Assistant
Medicare: May Accept Medicare Assignments
Practice Location: 1483 Devon Mill Way, Austell, GA 30168
Phone: 404-660-7646    
Reza H Mohammad, PAAA
Anesthesiologist Assistant
Medicare: May Accept Medicare Assignments
Practice Location: 3950 Austell Road, Austell, GA 30106
Phone: 770-732-3649    Fax: 770-732-3648
Ms. Whitney Ashlyn Wright, AA
Anesthesiologist Assistant
Medicare: May Accept Medicare Assignments
Practice Location: 3950 Austell Rd, Austell, GA 30106
Phone: 770-732-5570    
Mbuomda Nasah Lima, PAAA
Anesthesiologist Assistant
Medicare: May Accept Medicare Assignments
Practice Location: 3950 Austell Rd, Austell, GA 30106
Phone: 770-732-3649    Fax: 770-732-3648
Elizabeth Jean Stubbs, AA-C
Anesthesiologist Assistant
Medicare: May Accept Medicare Assignments
Practice Location: 3950 Austell Rd, Austell, GA 30106
Phone: 770-732-4000    
Melissa Wolff, PAAA
Anesthesiologist Assistant
Medicare: May Accept Medicare Assignments
Practice Location: 3950 Austell Rd, Austell, GA 30106
Phone: 770-874-1911    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.